New Treatment Approaches to Emotional Problems after TBI
New Research on Treatment for Emotional Issues after TBI Presented in Journal of Head Trauma Rehabilitation
11-Sep-2017 10:00 AM EDT
Newswise — September 11, 2017 – Patients with traumatic brain injury (TBI) commonly have emotional difficulties—a persistent problem with limited treatment options. New approaches to treatment for emotional deficits after TBI are presented in the September/October special issue of the Journal of Head Trauma Rehabilitation (JHTR). The official journal of the Brain Injury Association of America, JHTR is published by Wolters Kluwer.
One study evaluates videoconferencing technology to provide training in emotional regulation skills, in an innovative "telerehabilitation" approach that may expand access to treatment for patients with varying types of emotional challenges after TBI. "High-quality studies aimed at improving emotional functioning following TBI needs to be a priority; the well-being and life quality of our patients depend on it," writes Guest Editor Dawn Neuman, PhD, of Indiana University School of Medicine at Indianapolis.
New Treatment Approaches to Emotional Problems after TBI
Many patients with TBI experience disruptions in emotional functioning, including problems in awareness, recognition, expression, and regulation of emotions. "Of the vast array of consequences of TBI, emotional deficits are among the most prevalent, persistent, and difficult to treat," according to Dr. Neumann. Deficits in emotional regulation can affect patients' lives in many ways, including a reduced ability to participate in and benefit from other rehabilitation treatments.
Yet emotional issues after TBI remain "grossly understudied," especially in terms of treatment. The seven original research papers in the special issue evaluate innovative treatments for common emotional problems after TBI.
Theo Tsaousides, PhD, and colleagues of Icahn School of Medicine at Mount Sinai, New York, evaluated a web-based intervention to improve emotional regulation after TBI. The study included 91 adults with a history of TBI and current problems with emotional regulation, based on the "Difficulties in Emotional Regulation Scale" (DERS). Average time since TBI was about ten years. In nearly half of patients, the severity of TBI was rated mild.
Over 12 weeks, participants received 24 one-hour emotional regulation skills training sessions. The group sessions were delivered by videoconference, supervised by experienced rehabilitation neuropsychologists. The program provided education on how TBI affects emotional functioning, followed by training, practice, and feedback on specific strategies for improving emotional regulation skills in everyday life.
At the end of the 12-week program, the participants showed meaningful improvements in emotional regulation, including "medium to large" effects on all aspects measured by the emotional regulation questionnaire. Follow-up assessment 12 weeks beyond the treatment period showed continued improvement.
Measures of positive emotions, satisfaction with life, and problem-solving skills also improved significantly. Participants felt they made substantial progress toward their personal goals. Nearly 90 percent reported moderate to large improvements in their capacity for emotional regulation skills.
The use of videoconferencing technology could help to overcome distance and travel barriers to treatment, while maintaining the benefits of group interventions. The study recruited participants from 33 states and five countries. Dr. Tsaousides comments: "This technology allowed us to create an online educational environment that, in addition to providing skill training, enabled people who were hundreds and thousands of miles apart—many of whom had been isolated from support communities—to connect, share, and learn from one another."
Other papers in the special issue report on treatments targeting emotional self-awareness, social-emotional perception, anger and aggression, and depression after TBI. While the studies are an important step forward, "The state of the science for studying and treating emotional deficits in people with TBI is sorely lagging behind the needs," Dr. Neumann writes. "A lot more evidence-based research is needed to support more confident treatment recommendations."
Article: “Improving Emotion Regulation Following Web-Based Group Intervention for Individuals With Traumatic Brain Injury” (doi: 10.1097/HTR.0000000000000345)
About The Journal of Head Trauma Rehabilitation
The Journal of Head Trauma Rehabilitation is a leading, peer-reviewed resource that provides up-to-date information on the clinical management and rehabilitation of persons with traumatic brain injuries. Six issues each year aspire to the vision of “knowledge informing care” and include a wide range of articles, topical issues, commentaries and special features. It is the official journal of the Brain Injury Association of America.
About the Brain Injury Association of America
The Brain Injury Association of America is the country’s oldest and largest nationwide brain injury advocacy organization. Our mission is to advance awareness, research, treatment and education and to improve the quality of life for all individuals impacted by brain injury. Through advocacy, we bring help, hope and healing to millions of individuals living with brain injury, their families and the professionals who serve them.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.